Neurocrine Biosciences Inc (NBIX) — Net Asset Momentum
Neurocrine Biosciences Inc (NBIX) recorded a net asset momentum of 25.6% as of December 2025, with net assets of $3.25 Billion USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Neurocrine Biosciences Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Neurocrine Biosciences Inc Net Asset Momentum (1996–2025)
This chart tracks Neurocrine Biosciences Inc's year-over-year net asset growth across 30 annual reporting periods from 1996 to 2025. The most recent momentum reading is +25.6%, with net assets of $3.25 Billion USD as of December 2025. Read NBIX current and long-term liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Neurocrine Biosciences Inc (1996–2025)
The table below shows the complete annual net asset history for Neurocrine Biosciences Inc from 1996 to 2025, covering 30 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see market cap of Neurocrine Biosciences Inc.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $3.25 Billion | $4.63 Billion | $1.38 Billion | ▲ +25.6% |
| 2024 | $2.59 Billion | $3.72 Billion | $1.13 Billion | ▲ +16.0% |
| 2023 | $2.23 Billion | $3.25 Billion | $1.02 Billion | ▲ +30.7% |
| 2022 | $1.71 Billion | $2.37 Billion | $660.90 Million | ▲ +24.3% |
| 2021 | $1.37 Billion | $2.07 Billion | $698.50 Million | ▲ +22.0% |
| 2020 | $1.13 Billion | $1.73 Billion | $608.50 Million | ▲ +76.8% |
| 2019 | $636.90 Million | $1.31 Billion | $669.10 Million | ▲ +32.5% |
| 2018 | $480.76 Million | $993.15 Million | $512.39 Million | ▲ +29.2% |
| 2017 | $372.14 Million | $817.59 Million | $445.45 Million | ▲ +18.2% |
| 2016 | $314.88 Million | $365.09 Million | $50.21 Million | ▼ -25.8% |
| 2015 | $424.45 Million | $474.79 Million | $50.33 Million | ▲ +103.4% |
| 2014 | $208.70 Million | $243.03 Million | $34.33 Million | ▲ +73.3% |
| 2013 | $120.41 Million | $154.68 Million | $34.27 Million | ▼ -22.0% |
| 2012 | $154.37 Million | $195.98 Million | $41.61 Million | ▲ +156.9% |
| 2011 | $60.08 Million | $138.37 Million | $78.29 Million | ▲ +210.6% |
| 2010 | $19.34 Million | $144.42 Million | $125.08 Million | ▲ +389.3% |
| 2009 | $3.95 Million | $70.82 Million | $66.86 Million | ▼ -89.2% |
| 2008 | $36.77 Million | $118.18 Million | $81.41 Million | ▼ -69.0% |
| 2007 | $118.70 Million | $276.65 Million | $157.96 Million | ▼ -62.3% |
| 2006 | $314.72 Million | $389.68 Million | $74.96 Million | ▼ -19.3% |
| 2005 | $390.10 Million | $483.12 Million | $93.02 Million | ▼ -0.9% |
| 2004 | $393.83 Million | $519.22 Million | $125.39 Million | ▲ +0.7% |
| 2003 | $391.12 Million | $554.96 Million | $163.84 Million | ▲ +74.4% |
| 2002 | $224.25 Million | $266.54 Million | $42.28 Million | ▼ -27.8% |
| 2001 | $310.39 Million | $346.35 Million | $35.96 Million | ▲ +90.2% |
| 2000 | $163.21 Million | $185.96 Million | $22.75 Million | ▲ +69.3% |
| 1999 | $96.40 Million | $109.20 Million | $12.80 Million | ▲ +33.9% |
| 1998 | $72.00 Million | $80.50 Million | $8.50 Million | ▼ -13.5% |
| 1997 | $83.20 Million | $91.90 Million | $8.70 Million | ▲ +14.3% |
| 1996 | $72.80 Million | $78.00 Million | $5.20 Million | — |